These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35382979)
41. The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus. Agrawal S; Pandey MK J Hematother Stem Cell Res; 2003 Dec; 12(6):749-56. PubMed ID: 14977483 [TBL] [Abstract][Full Text] [Related]
42. Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function. Liang S; Zhang W; Horuzsko A Eur J Immunol; 2006 Sep; 36(9):2457-71. PubMed ID: 16897816 [TBL] [Abstract][Full Text] [Related]
48. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Aractingi S; Briand N; Le Danff C; Viguier M; Bachelez H; Michel L; Dubertret L; Carosella ED Am J Pathol; 2001 Jul; 159(1):71-7. PubMed ID: 11438456 [TBL] [Abstract][Full Text] [Related]
49. Immune modulation of HLA-G dimer in maternal-fetal interface. Kuroki K; Maenaka K Eur J Immunol; 2007 Jul; 37(7):1727-9. PubMed ID: 17587197 [TBL] [Abstract][Full Text] [Related]
50. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal. Menier C; Riteau B; Carosella ED; Rouas-Freiss N Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588 [TBL] [Abstract][Full Text] [Related]
51. A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential. Rizzo R; Lanzoni G; Stignani M; Campioni D; Alviano F; Ricci F; Tazzari PL; Melchiorri L; Scalinci SZ; Cuneo A; Bonsi L; Lanza F; Bagnara GP; Baricordi OR Cytotherapy; 2011 May; 13(5):523-7. PubMed ID: 21171826 [TBL] [Abstract][Full Text] [Related]
52. [HLA-G: from feto-maternal tolerance to organ grafting]. Carosella ED Bull Mem Acad R Med Belg; 2009; 164(3-4):87-99; discussion 99-101. PubMed ID: 20120086 [TBL] [Abstract][Full Text] [Related]
53. HLA-G expression in cancers: potential role in diagnosis, prognosis and therapy. Yan WH Endocr Metab Immune Disord Drug Targets; 2011 Mar; 11(1):76-89. PubMed ID: 21348818 [TBL] [Abstract][Full Text] [Related]
54. A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis. Morandi F; Ferretti E; Bocca P; Prigione I; Raffaghello L; Pistoia V PLoS One; 2010 Jul; 5(7):e11763. PubMed ID: 20668702 [TBL] [Abstract][Full Text] [Related]
55. Tumor infiltrating and peripheral CD4 Jacquier A; Lambert T; Delattre JF; Djouadou M; Vérine J; Dumont C; Desgrandchamps F; Carosella ED; LeMaoult J; Rouas-Freiss N Cancer Lett; 2021 Oct; 519():105-116. PubMed ID: 34186161 [TBL] [Abstract][Full Text] [Related]
56. Stranger in a strange land. Hunt JS Immunol Rev; 2006 Oct; 213():36-47. PubMed ID: 16972895 [TBL] [Abstract][Full Text] [Related]
57. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2. Huang J; Burke P; Yang Y; Seiss K; Beamon J; Cung T; Toth I; Pereyra F; Lichterfeld M; Yu XG J Virol; 2010 Oct; 84(20):10784-91. PubMed ID: 20702625 [TBL] [Abstract][Full Text] [Related]
58. CD8(+)HLA-G(+) regulatory T cells are expanded in HIV-1-infected patients. Lozano JM; González R; Luque J; Frias M; Rivero A; Peña J Viral Immunol; 2009 Dec; 22(6):463-5. PubMed ID: 19951184 [TBL] [Abstract][Full Text] [Related]